- recruitingTherapeutic exploratory (Phase II)
Prospective, monocentric, exploratory phase II study for the evaluation of the diagnostic use of the tracer PET (18F) -Flutemetamol (Vizamyl®) in patients with cardiac amyloidosis
This study is looking at a special scan called a PET scan to see how a new tracer (a tiny amount of a radioactive substance) called Vizamyl works. We want to see how much of it is taken up by the heart in people with different types of cardiac amyloidosis.
Italy - recruiting
Hybrid Florbetaben PET/MRI for Imaging of Cardiac Amyloidosis
This study uses advanced scans (PET/MRI) to better understand heart problems caused by amyloidosis. We're looking at how these scans can predict future heart issues in people with the condition. The goal is to improve how we check and help patients.
Germany - recruitingPHASE1
Test-retest Study With [18F]FBB in Cardiac Amyloidosis
This study looks at how well a special scan, called a PET scan, can consistently find deposits in the heart caused by a condition called cardiac amyloidosis. We will check if the scan gives reliable results when done more than once.
United Kingdom - recruiting
Cardiac Amyloidosis Registry of University Hospital Leipzig
This study is a registry collecting information from people with a heart condition called cardiac amyloidosis being treated at University Hospital Leipzig. It gathers details on symptoms, tests, and treatments to better understand the condition beyond typical clinical trials.
Germany - recruiting
Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease
This study looks at a possible link between heart problems and Alzheimer's disease. Researchers will use special scans to see if a protein called amyloid, found in Alzheimer's, also builds up in the heart. This could help diagnose both conditions better.
Germany - recruitingNA
PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY
This study looks at whether checking your weight at home can help people with a heart condition called cardiac amyloidosis. It aims to see if spotting fluid build-up early can stop you from needing to go to hospital.
United Kingdom